The outsourced cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031, claims Roots Analysis

Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportunities for consumable providers having capabilities for raw material production

For additional details, please visit

comments (0)

64 more from jameshebrew